Table 1.
Characteristics of the cohort of patients, nodules and treatment characteristics.
| Data of patients (n = 162) | Data of nodules (n = 342) | ||||||
|---|---|---|---|---|---|---|---|
| N | % | N | % | ||||
| Sex | Male Female |
111 51 |
69% 31% |
Lesions’ site | Head/neck/scalp Trunk Limbs |
223 31 88 |
65% 9% 26% |
| ECOG | Fully active Restricted in physically strenuous activity Ambulatory and capable of all self-care Capable of only limited self-care Completely disabled Unknown |
80 54 10 11 3 4 |
49% 34% 6% 7% 2% 2% |
Current intensity delivered | 0-3 Å 3-7 >7 Å |
144 172 26 |
42% 50% 8% |
| Tumor presentation | Primary (persistent/recurrent*) Locally advanced |
104 58 |
64% 36% |
Electrode | Hexagonal Linear/Finger Plate Multiple |
205 110 18 9 |
60% 32% 5% 3% |
| T | 1 2 3 4 x |
82 44 16 10 10 |
51% 27% 10% 6% 6% |
Preirradiated lesions | Yes | 59 | 17% |
| N | 0 1 2 X |
132 9 10 11 |
81% 6% 6% 7% |
Lymphoedema | Yes | 27 | 8% |
| M | 0 1 x |
151 3 8 |
93% 2% 5% |
Lesions’ size | <30 mm ≥30 mm |
241 101 |
70% 30% |
| Previous treatments | No Surgery Radiotherapy Chemotherapy Cryotherapy Electrochemotherapy Photodynamic therapy Surg+RT CT+RT Surg+CT Surg+Cryo Surg+ECT Surg+CT+RT Surg+RT+PDT Surg+RT+Cryo CT+RT+TT Surg+CT+RT+Immuno unknown |
49 43 4 1 8 1 1 24 2 3 3 1 7 1 1 1 1 11 |
30% 27% 2% 0.6% 5% 0.6% 0.6% 15% 0.6% 2% 2% 0.6% 4% 0.6% 0.6% 0.6% 0.6% 7% |
||||
| Drug administration | Intratumoural Intravenous |
28 134 |
17% 83% |
||||
| Anesthesia | Local/regional general |
69 93 |
43% 57% |
||||
Surg, surgery; RT, radiotherapy; Cryo, cryotherapy; ECT, electrochemotherapy; CT, chemotherapy; PDT, photodynamic therapy; TT, target therapy; Immuno, immunotherapy; *persistent, not responding to previous conventional treatments; recurrent, responded to previous conventional treatments but then recurred.